DENVER, Nov. 1 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, will be presenting at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference to be held November 5-7 at the New York Palace Hotel in New York City.
On Tuesday, November 6th, at 11:15 a.m. EST, Dr. Michael Ruxin, Chief Executive Officer of Global Med Technologies, will give a 20-minute presentation in the Spellman Room, regarding Global Med's business and discuss its unique value proposition, latest developments, financial performance and prospects. Management will also participate in a question and answer session following the presentation and in one-on-one meetings throughout the day.
The Acumen Biofin Rodman & Renshaw Healthcare Conference will include presentations by over 350 companies, as well as experts from the medical, scientific and investment communities. The categories of presentation include autoimmune diseases, cardiovascular diseases, CNS, drug delivery, gene therapy, infectious diseases, medical devices, oncology, specialty pharmaceuticals, and therapeutic vaccines. A vast number of Investors, venture capitalists, company executives, scientists and other industry leaders are expected to attend.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical
information technology company providing information management software
products and services to the healthcare industry. Its Wyndgate
Technologies(R) division is a leading supplier of information management
systems to U.S. and international blood centers and hospital transfusion
centers. Each year, Wyndgate's products and services manage more than eight
million blood components, representi
|SOURCE Global Med Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved